AXOVANT GENE THERAPIES LTD

CUSIP: G0750W203 Class: COM

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 120,925 Value ($000) $559 Avg Close — Range —
Q2 2020
Shares 53,384 Value ($000) $151 Avg Close — Range —
Q1 2020
Shares 41,037 Value ($000) $100 Avg Close — Range —
Q4 2019
Shares 40,343 Value ($000) $207 Avg Close — Range —
Q3 2019
Shares 12,861 Value ($000) $83 Avg Close — Range —
Q2 2019
Shares 25,561 Value ($000) $159 Avg Close — Range —